Opto Circuits sharpens focus on Emerging Markets

Subsidiary Eurocor ready to launch new brands of bare metal stents

Eurocor GmbH, the wholly-owned German subsidiary of Opto Circuits (India) Limited, India’s leading developer and manufacturer of patient monitoring systems and interventional products, today received CE (Conformité Européen) mark on coronary bare metal stent brands eMagic and eFlex. Both products are being immediately made available to Eurocor’s global distributors who sense great potential in selling leading treatment options in emerging market economies such as those in Asia, Africa and Latin America.

eMagic is an uncoated stent on a cobalt chromium base and eFlex is an uncoated stent on a stainless steel base. Both have been certified for their quality standards and are being launched by Eurocor as a diversified addition to its present portfolio of stenting products.

Dr. Rembert Pogge,Director – Clinical & Publication, Eurocor GmbH, commented on the development, “There is an urgent need to address the growing incidence of heart-related lifestyle diseases in the developing countries by making effective and proven treatments easily accessible to clinicians in these geographies. The launch of eMagic and eFlex by Eurocor is one such step in this direction.”

About Eurocor GmbH
Eurocor GmbH is a Bonn (Germany)-based rapidly growing life sciences company specialising in the research and development of cardiovascular catheter products and coronary stent technologies. Eurocor’s products are used in minimally invasive cardiovascular surgery and comply with biological and biomechanical principles to offer highly flexible, adaptable solutions.

Opto Circuits India acquired Eurocor GmbH in 2006.
Visit us at www.eurocor.de

About Opto Circuits (India) Ltd.
Opto Circuits (India) Ltd. (OCI) (BSE Code: 532391; NSE Symbol: OPTOCIRCUI) is an Indian MNC in the business of design, development, manufacture and marketing of healthcare equipment and interventional products. The product profile includes digital thermometers, sensors, pulse oximeters, patient monitoring systems, anesthesia analyzers, stents, catheters and other innovative products. It is presently a Group of 14 companies with a consolidated total sales of Rs.1077 crores (FY10) and it is headquartered in Bengaluru, Karnataka, India. Its key markets are US, Europe and South East Asia. It was ranked as one amongst 200 Best Under a Billion companies in AsiaPac by Forbes Asia in 2009, 2008.
Visit us at www.optoindia.com